T
PFE icon

TOBAM’s Pfizer PFE Stock Holding History

TOBAM’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28K Sell
1,173
-13,856
-92% -$362K 0.01% 241
2026
Q1 		$422K Sell
15,029
-311
-2% -$8.28K 0.11% 152
2025
Q4 		$382K Buy
+15,340
New +$387K 0.09% 159
2025
Q3 		– Sell
-28,898
Closed -$700K – 267
2025
Q2 		$700K Sell
28,898
-37,857
-57% -$883K 0.27% 74
2025
Q1 		$1.69M Sell
66,755
-158,987
-70% -$4.16M 0.72% 49
2024
Q4 		$5.99M Sell
225,742
-168,177
-43% -$4.56M 1.83% 14
2024
Q3 		$11.4M Sell
393,919
-117,436
-23% -$3.43M 2.08% 13
2024
Q2 		$14.3M Sell
511,355
-396,687
-44% -$10.9M 2.24% 11
2024
Q1 		$25.2M Buy
908,042
+18,715
+2% +$519K 2.26% 15
2023
Q4 		$25.6M Sell
889,327
-60,518
-6% -$1.83M 2.24% 17
2023
Q3 		$31.5M Sell
949,845
-82,818
-8% -$2.93M 2.53% 11
2023
Q2 		$37.9M Sell
1,032,663
-35,284
-3% -$1.37M 2.86% 4
2023
Q1 		$43.6M Buy
1,067,947
+161,346
+18% +$6.97M 2.87% 3
2022
Q4 		$46.5M Sell
906,601
-27,806
-3% -$1.33M 3.08% 1
2022
Q3 		$40.9M Buy
934,407
+49,309
+6% +$2.4M 2.86% 2
2022
Q2 		$46.4M Sell
885,098
-149,451
-14% -$7.62M 2.91% 1
2022
Q1 		$53.6M Buy
1,034,549
+662,610
+178% +$34.4M 2.69% 2
2021
Q4 		$22M Buy
371,939
+326,064
+711% +$16.2M 0.99% 40
2021
Q3 		$1.97M Buy
45,875
+26,174
+133% +$1.16M 0.08% 105
2021
Q2 		$771K Hold
19,701
– – 0.03% 131
2021
Q1 		$714K Hold
19,701
– – 0.03% 128
2020
Q4 		$725K Sell
19,701
-390
-2% -$14.3K 0.03% 133
2020
Q3 		$700K Buy
+20,091
New +$704K 0.04% 125

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TOBAM's PFE Position: Q2 2026 in Review

TOBAM reduced its Pfizer (PFE) stake by 92% in Q2 2026, selling an estimated $362K and leaving 1,173 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #241.

TOBAM first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $53.6M in Q1 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TOBAM held 1,173 shares of Pfizer worth $28K as of Q2 2026.
  • TOBAM sold 13,856 Pfizer shares in Q2 2026, an estimated $362K.
  • Pfizer made up 0.01% of TOBAM's portfolio in Q2 2026, its #241 holding.
  • TOBAM first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • TOBAM's Pfizer position peaked at $53.6M in Q1 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.